The company has been working with pharmaceutical companies to support clinical trials and drug development with its unique combined DNA and RNA liquid biopsy platform.
Results from a study have spurred a new prospective trial comparing arrays, sequencing, and several single-marker assays in men receiving hormonal therapies.
A University of Toronto team developed the probes to improve upon its previously described electrochemical clamp assay technology.
Teneovita will distribute Biocept's test services to hospitals, oncology centers, and individual medical practices throughout the country.
A study by researchers in Austria suggests read depth patterns upstream of transcription start sites can provide clues to gene expression.
Last month, the foundation, in partnership with the Washington State Department of Health, released seven educational videos about prenatal testing.
A Winthrop-University Hospital team showed that demethylated circulating cell-free DNA from dying oligodendrocytes is a biomarker for relapsing-remitting MS.
The researchers said that this property of ctDNA could be exploited to improve the sensitivity of liquid biopsies.
In a pilot study, investigators identified infection-causing agents by sequencing microbial DNA in patient blood samples.
Based on data from more than 6,000 clinical cases, the investigators from Switzerland advocated for an expansion of NIPT to cover additional alterations and associated phenotypes.
Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.
Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.
Slate's Jane Hu compares some at-home genetic tests to astrology.
In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.